Has the incidence of end-stage renal disease in the USA and other countries stabilized?

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 3, 2011, Pages 241-245

  Eggers, Paul W ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

demographic transition; economics; ESRD incidence; international renal disease

Indexed keywords

AGING; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIABETES MELLITUS; ECONOMIC ASPECT; HEALTH INSURANCE; HUMAN; KIDNEY FAILURE; POPULATION DYNAMICS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; UNITED STATES;

HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; POPULATION DYNAMICS; RENAL REPLACEMENT THERAPY; TIME FACTORS; UNITED STATES;

EID: 79955009057     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283454319     Document Type: Review

References (26)

1. Evans RW, Blagg CR, Bryan FA. Implications for healthcare policy: a social and demographic profile of hemodialysis patients in the United States. JAMA 1981; 245:487-491. (Pubitemid 11174716)
2. Eggers PW, Connerton R, McMullan M. The Medicare experience with endstage renal disease: trends in incidence, prevalence, and survival. Health Care Financ Rev 1984; 5:69-88.
3. Iglehard JK. Funding the end-stage renal disease program. N Engl J Med 1982; 306:492-496.
4. Kolata GB. NMC thrives selling dialysis. Science 1980; 208:379; 381-382.
5. US Renal Data System. USRDS 2010 annual data report. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.
6. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001; 12:2753-2758. (Pubitemid 33115423)
7. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with endstage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005; 16:3736-3741. (Pubitemid 46211296)
8. Eggers PW. The aging pandemic: demographic changes in the general and ESRD populations. Semin Dial 2009; 29:551-554.
9. McDonald S, McCredie M, Williams S, Stewart J. Factors influencing reported rates of treated end-stage renal disease. Adv Chron Kidney Dis 2005; 12:32-38. (Pubitemid 40255601)
10. Gurland HJ, Lysaght MJ. Future trends in renal replacement. Ther Artif Organs 1993; 17:267-271.
11. Schena FP. Epidemiology of end-stage renal disease: international comparisons of renal replacement therapy. Kidney Int 2000; 57:S39-S45.
12. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13:S37-S40. (Pubitemid 34008176)
13. Moeller S, Gioberge S, Brown G. ESRD patients in 2001: global overview of patients, treatment modalities and development trends. Nephrol Dial Transplant 2002; 17:2071-2076. (Pubitemid 35469036)
14. Grassman A, Gioberge S,Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20:2587-2593. (Pubitemid 41672250)
15. Chugh KS, Jha V, Chugh S. Economics of dialysis and renal transplantation in the developing world. Transplant Proc 1999; 31:3275-3277.
16. Just PM, deCharro FT, Tschosik EA, et al. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 2008; 23:2365-2373. (Pubitemid 351957587)
17. Barsoum RS. Overview: end-stage renal disease in the developing world. Artif Organs 2002; 26:737-746. (Pubitemid 35013754)
18. Prodjosudjadi W, Suhardjono A. End-stage renal disease in Indonesia: treatment development. Ethn Dis 2009; 19:S1-34-S1-36.
19. Hada R, Khakurel S, Agrawal RK, et al. Incidence of end stage renal disease on renal replacement in Nepal. Kathmandu Univ Med J 2009; 7:301-305.
20. Haghighi AN, Broumand B, D'Amico M, et al. The epidemiology of end-stage renal disease in Iran in an international perspective. Nephrol Dial Transplant 2002; 17:28-32. (Pubitemid 34093005)
21. Agarwal SK, Srivastava RK. Chronic kidney disease in India: challenges and solutions. Nephron Clin Pract 2009; 111:c197-c203.
22. Zuo L, Wang M. Current status of hemodialysis treatment in Beijing, China. Ethn Dis 2006; Spring:S2-31-S2-34. (Pubitemid 46959336)
23. Zuo L, Wang M. Current burden and probable increasing incidence of ESRD in China. Clin Nephrol 2010; 74(S1):20-22.
24. Lugon JR. End-stage renal disease and chronic kidney disease in Brazil. Ethn Dis 2007; 19:S1-S7.
25. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006; 354:997-999. (Pubitemid 43357803)
26. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87:4-14.